Magna Graecia University
Also known as: Chair of Obstetrics and Gynecology, University Magna Graecia Catanzaro, Italy | Department of Obstetrics and Gynecology, University Magna Graecia of Catanzaro | Department of Obstetrics & Gynecology - University Magna Graecia of Catanzaro | Department of Obstetrics & Gynecology, University Magna Graecia of Catanzaro | Federico Longhini | Gynecologic Unit, Cancer Center of Excellence Tommaso Campanella of Catanzaro | Magna Graecia University | Magna Graecia University of Catanzaro | Magna Graecia University of Catanzaro, Nephrology Unit | Paolo Navalesi | Prof Antonino Belfiore | Tommaso Campanella of Catanzaro | Translational Medical Oncology Unit, AOU MaterDomini and Magna Graecia University | Uniersity Magna Graecia of Catanzaro | Università Magna Grecia, Catanzaro | University Magna Graecia | University Magna Graecia Catanzaro | University of Cantanzaro | University of Catanzaro
Highest phase reached
Phase 4
First clinical trial
Jun 1, 1998Last known activity
Oct 1, 2022
Timeline
1990s
- Jun 1, 1998
Magna Graecia University— Founded
Drugs by trial phase (45 distinct, 49 trials)
Phase 4 (28 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (9 own, 0 via acquisition)
Indications
Studied for
- Anovulation
- Coronavirus Infections
- Diabetes, Gestational
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Dyslipidemias
- Endometriosis
- Glaucoma
- Glaucoma, Open-Angle
- Glomerulonephritis
- Glomerulonephritis, IGA
- Hypersensitivity
- Hypertension
- Infections
- Infertility
- Insulin Resistance
- Leiomyoma
- Lung Diseases, Interstitial
- Metabolic Diseases
- Myofibroma
- Osteoarthritis
- Osteoarthritis, Knee
- Pelvic Pain
- Pneumonia
- Polycystic Ovary Syndrome
- Polyps
- Severe Acute Respiratory Syndrome
- Syndrome
- Uterine Neoplasms
- Vascular System Injuries
Recent trials (50)
- NCT06165692Sponsor investigatorN/AOct 1, 2022
- NCT06165692Lead sponsorN/AOct 1, 2022
- NCT05334654Overall official - principal investigatorN/AApr 20, 2022
- NCT05334654Reponsible party - principal investigatorN/AApr 20, 2022
- NCT05334654Lead sponsorN/AApr 20, 2022
- NCT05830747Reponsible party - principal investigatorPhase 4Feb 1, 2022
- NCT05830747Lead sponsorPhase 4Feb 1, 2022
- NCT05830747Overall official - principal investigatorPhase 4Feb 1, 2022
- NCT04392557Reponsible party - principal investigatorPhase 4Jul 31, 2020
- NCT04392557Lead sponsorPhase 4Jul 31, 2020
- NCT04390061CollaboratorPhase 2Jun 30, 2020
- NCT04385043Lead sponsorPhase 2/Phase 3May 1, 2020
- NCT04385043Reponsible party - principal investigatorPhase 2/Phase 3May 1, 2020
- NCT04322344Lead sponsorPhase 2/Phase 3Mar 23, 2020
- NCT04322344Reponsible party - principal investigatorPhase 2/Phase 3Mar 23, 2020
Details
- Founded
- Catanzaro, IT Jun 1, 1998
- Last known activity
- Oct 1, 2022